Effect of statins on outcomes in immunosuppressed patients with bloodstream infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 1, 2011, Pages 77-82

  Viasus, D ^a   Gudiol, C ^a   Fernandez Sabe N ^a   Cabello, I ^a   Garcia Vidal, C ^a   Cisnal, M ^a   Duarte, R ^b   Antonio, M ^b   Carratala J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOODSTREAM INFECTION; CANCER PATIENT; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLID TUMOR; SPAIN; SURVIVAL RATE; TERTIARY HEALTH CARE;

AGED; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; SEPSIS; SPAIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78751571104     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1056-2     Document Type: Article

References (22)

1. G Maschmeyer A Haas 2008 The epidemiology and treatment of infections in cancer patients Int J Antimicrob Agents 31 193 197 10.1016/j.ijantimicag.2007. 06.014 1:CAS:528:DC%2BD1cXitVOktbw%3D 10.1016/j.ijantimicag.2007.06.014 17703922 (Pubitemid 351232171)
2. R Feld 2008 Bloodstream infections in cancer patients with febrile neutropenia Int J Antimicrob Agents 32 Suppl 1 S30 S33 10.1016/j.ijantimicag. 2008.06.017 1:CAS:528:DC%2BD1cXht1KmurvK 10.1016/j.ijantimicag.2008.06.017 18778919
3. A Moreno C Cervera J Gavaldá, et al. 2007 Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain Am J Transplant 7 2579 2586 10.1111/j.1600-6143.2007.01964.x 1:STN:280: DC%2BD2sngsVSisg%3D%3D 10.1111/j.1600-6143.2007.01964.x 17868067 (Pubitemid 47561608)
4. H Wisplinghoff H Seifert RP Wenzel, et al. 2003 Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States Clin Infect Dis 36 1103 1110 10.1086/374339 10.1086/374339 12715303 (Pubitemid 36553108)
5. JJ Brugts T Yetgin SE Hoeks, et al. 2009 The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 b2376 10.1136/bmj.b2376 1:STN:280:DC%2BD1Mvls1CltQ%3D%3D 10.1136/bmj.b2376 19567909
6. JK Liao U Laufs 2005 Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 89 118 10.1146/annurev.pharmtox.45.120403.095748 1:CAS:528: DC%2BD2MXisVWjtrY%3D 10.1146/annurev.pharmtox.45.120403.095748 15822172 (Pubitemid 40261799)
7. HY Sun N Singh 2009 Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients Clin Infect Dis 48 745 755 10.1086/597039 10.1086/597039 19193110
8. D Viasus C Garcia-Vidal F Gudiol, et al. 2010 Statins for community-acquired pneumonia: current state of the science Eur J Clin Microbiol Infect Dis 29 143 152 10.1007/s10096-009-0835-0 1:CAS:528:DC%2BC3cXnvFakug%3D%3D 10.1007/s10096-009-0835-0 19943074
9. F Gao L Linhartova AM Johnston, et al. 2008 Statins and sepsis Br J Anaesth 100 288 298 10.1093/bja/aem406 1:CAS:528:DC%2BD1cXitlGmtb0%3D 10.1093/bja/aem406 18276651 (Pubitemid 351773654)
10. J Hsu DR Andes V Knasinski, et al. 2009 Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients Eur J Clin Microbiol Infect Dis 28 1343 1351 10.1007/s10096-009-0787-4 1:CAS:528:DC%2BD1MXhtlKhsb3I 10.1007/s10096-009-0787-4 19669657
11. ND Friedman KS Kaye JE Stout, et al. 2002 Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 791 797 12435215
12. AP Liappis VL Kan CG Rochester, et al. 2001 The effect of statins on mortality in patients with bacteremia Clin Infect Dis 33 1352 1357 10.1086/323334 1:CAS:528:DC%2BD3MXotVWgur4%3D 10.1086/323334 11565076 (Pubitemid 32955186)
13. P Kruger K Fitzsimmons D Cook, et al. 2006 Statin therapy is associated with fewer deaths in patients with bacteraemia Intensive Care Med 32 75 79 10.1007/s00134-005-2859-y 10.1007/s00134-005-2859-y 16283159 (Pubitemid 43039379)
14. RW Thomsen HH Hundborg SP Johnsen, et al. 2006 Statin use and mortality within 180 days after bacteremia: a population-based cohort study Crit Care Med 34 1080 1086 10.1097/01.CCM.0000207345.92928.E4 1:CAS:528:DC%2BD28Xis1ersbc%3D 10.1097/01.CCM.0000207345.92928.E4 16484926
15. JD Chalmers A Singanayagam MP Murray, et al. 2008 Prior statin use is associated with improved outcomes in community-acquired pneumonia Am J Med 121 1002 1007 10.1016/j.amjmed.2008.06.030 1:CAS:528:DC%2BD1cXht12gu7%2FP 10.1016/j.amjmed.2008.06.030 18954848
16. D Khemasuwan ML Divietro K Tangdhanakanond, et al. 2010 Statins decrease the occurrence of venous thromboembolism in patients with cancer Am J Med 123 60 65 10.1016/j.amjmed.2009.05.025 1:CAS:528:DC%2BD1MXhs1Wit7nO 10.1016/j.amjmed.2009.05.025 20102993
17. IF Gazi EN Liberopoulos VG Athyros, et al. 2006 Statins and solid organ transplantation Curr Pharm Des 12 4771 4783 1:CAS:528:DC%2BD2sXmsFCntQ%3D%3D 10.2174/138161206779026308 17168777 (Pubitemid 44841765)
18. C Agustí A Rañó M Rovira, et al. 2004 Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients Thorax 59 1081 1088 10.1136/thx.2004.030551 10.1136/thx.2004.030551 15563709 (Pubitemid 39573929)
19. MB Fessler SK Young S Jeyaseelan, et al. 2005 A role for hydroxy-methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense Am J Respir Crit Care Med 171 606 615 10.1164/rccm.200406-729OC 10.1164/rccm.200406-729OC 15591471 (Pubitemid 40365416)
20. SR Majumdar FA McAlister DT Eurich, et al. 2006 Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study BMJ 333 999 10.1136/bmj.38992.565972.7C 10.1136/bmj.38992.565972.7C 17060337 (Pubitemid 44764347)
21. L Björkhem-Bergman P Bergman J Andersson, et al. 2010 Statin treatment and mortality in bacterial infections-a systematic review and meta-analysis PLoS ONE 5 e10702 10.1371/journal.pone.0010702 10.1371/journal.pone.0010702 20502712
22. IM Tleyjeh T Kashour FA Hakim, et al. 2009 Statins for the prevention and treatment of infections: a systematic review and meta-analysis Arch Intern Med 169 1658 1667 10.1001/archinternmed.2009.286 19822822